The result: Increased lipolysis : Fat cells release stored fatty acids for use as fuel Inhibited lipogenesis : Dietary fats are less readily converted to stored body fat No significant IGF-1 stimulation : Means no growth of existing tumors or cancer risk amplification that concerns some clinicians with full GH No significant glucose disruption : Unlike full HGH, which causes insulin resistance at therapeutic doses, AOD-9604 shows minimal glucose impact in studies This makes it uniquely well-suited for fat loss use cases where full HGH would be too blunt an instrument
These benefits showcase the potential of BPC-157 as a versatile therapeutic agent
Sleep problems often require a broader clinical look at mental health, nervous system regulation, daily routine, light exposure, stimulants, medications, hormones, pain, and breathing during sleep
Plasma glucose was measured with a glucometer, and insulin and leptin concentrations were analyzed via the U-PLEX Custom Metabolic Group 1 mouse assay [2]
Frequently asked questions Can I inject AOD 9604 and tirzepatide at the same site